Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pawel Muranski

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Journal for Immunotherapy of Cancer|July 1, 2021
TGM4: an immunogenic prostate-restricted antigenZoila A Lopez-Bujanda, Aleksandar Obradovic, Thomas R Nirschl, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2009
Adoptively transferred effector cells derived from naive rather than central memory CD8+ T cells mediate superior antitumor immunityChristian S Hinrichs, Zachary A Borman, Lydie Cassard, et al.
Cancer Cell|July 25, 2025
Adoptively transferred Th17 cells cooperate with host B cells to achieve durable tumor immunityAnna C Cole, Hannah M Knochelmann, Megan M Wyatt, et al.
Blood|November 9, 2016
A subset of virus-specific CD161<sup>+</sup> T cells selectively express the multidrug transporter MDR1 and are resistant to chemotherapy in AMLAbdullah Alsuliman, Muharrem Muftuoglu, Ahmad Khoder, et al.
Blood|October 26, 2010
Human effector CD8+ T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapyChristian S Hinrichs, Zachary A Borman, Luca Gattinoni, et al.
The Lancet. Haematology|January 15, 2016
Alemtuzumab in T-cell large granular lymphocytic leukaemia: interim results from a single-arm, open-label, phase 2 studyBogdan Dumitriu, Sawa Ito, Xingmin Feng, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 2, 2014
Ultra-low dose interleukin-2 promotes immune-modulating function of regulatory T cells and natural killer cells in healthy volunteersSawa Ito, Catherine M Bollard, Mattias Carlsten, et al.
Nature Medicine|June 15, 2023
Immune reconstitution inflammatory syndrome drives emergence of HIV drug resistance from multiple anatomic compartments in a person living with HIVAndrea Lisco, Camille Lange, Maura Manion, et al.
Immunity|December 20, 2011
Th17 cells are long lived and retain a stem cell-like molecular signaturePawel Muranski, Zachary A Borman, Sid P Kerkar, et al.
The Journal of Experimental Medicine|September 4, 2013
Retinoic acid controls the homeostasis of pre-cDC-derived splenic and intestinal dendritic cellsChristopher A Klebanoff, Sean P Spencer, Parizad Torabi-Parizi, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Journal for Immunotherapy of Cancer|July 1, 2021
TGM4: an immunogenic prostate-restricted antigenZoila A Lopez-Bujanda, Aleksandar Obradovic, Thomas R Nirschl, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2009
Adoptively transferred effector cells derived from naive rather than central memory CD8+ T cells mediate superior antitumor immunityChristian S Hinrichs, Zachary A Borman, Lydie Cassard, et al.
Cancer Cell|July 25, 2025
Adoptively transferred Th17 cells cooperate with host B cells to achieve durable tumor immunityAnna C Cole, Hannah M Knochelmann, Megan M Wyatt, et al.
Blood|November 9, 2016
A subset of virus-specific CD161<sup>+</sup> T cells selectively express the multidrug transporter MDR1 and are resistant to chemotherapy in AMLAbdullah Alsuliman, Muharrem Muftuoglu, Ahmad Khoder, et al.
Blood|October 26, 2010
Human effector CD8+ T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapyChristian S Hinrichs, Zachary A Borman, Luca Gattinoni, et al.
The Lancet. Haematology|January 15, 2016
Alemtuzumab in T-cell large granular lymphocytic leukaemia: interim results from a single-arm, open-label, phase 2 studyBogdan Dumitriu, Sawa Ito, Xingmin Feng, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 2, 2014
Ultra-low dose interleukin-2 promotes immune-modulating function of regulatory T cells and natural killer cells in healthy volunteersSawa Ito, Catherine M Bollard, Mattias Carlsten, et al.
Nature Medicine|June 15, 2023
Immune reconstitution inflammatory syndrome drives emergence of HIV drug resistance from multiple anatomic compartments in a person living with HIVAndrea Lisco, Camille Lange, Maura Manion, et al.
Immunity|December 20, 2011
Th17 cells are long lived and retain a stem cell-like molecular signaturePawel Muranski, Zachary A Borman, Sid P Kerkar, et al.
The Journal of Experimental Medicine|September 4, 2013
Retinoic acid controls the homeostasis of pre-cDC-derived splenic and intestinal dendritic cellsChristopher A Klebanoff, Sean P Spencer, Parizad Torabi-Parizi, et al.
Pageof 7